C-Reactive Protein Levels in Schizophrenia
Clinical Schizophrenia & Related Psychoses · 2014-01 · 7 (4) · 223-230
DOI: 10.3371/csrp.micu.020813 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Schizophrenia & Related Psychoses, 2014-01. Verfasst von Brian J. Miller und 2 weiteren Autor:innen. Die Arbeit wurde bisher 240-mal zitiert (Crossref) und nennt 49 Literaturangaben.
Abstract (Originalsprache)
There is an impression in the literature that schizophrenia is associated with increased inflammation, including abnormal blood levels of the acute phase reactant C-reactive protein (CRP). We performed a meta-analysis of blood CRP levels to estimate the overall effect size, as well as a pooled analysis of the prevalence of an elevated CRP level in patients with schizophrenia and related disorders. We identified articles by searching PubMed, PsycInfo, and ISI, and the reference lists of identified studies. Eight studies met the inclusion criteria for the meta-analysis, and five studies were included in the pooled analysis. CRP levels were significantly increased in patients compared to controls (effect size=0.45, 95% confidence interval 0.34-0.55, p
Zitieren
APA
Miller, B. J., Culpepper, N., & Rapaport, M. H. (2014). C-Reactive Protein Levels in Schizophrenia. Clinical Schizophrenia & Related Psychoses, 7(4), 223-230. https://doi.org/10.3371/csrp.micu.020813
Vancouver
Miller BJ, Culpepper N, Rapaport MH. C-Reactive Protein Levels in Schizophrenia. Clinical Schizophrenia & Related Psychoses. 2014;7(4):223-230. doi:10.3371/csrp.micu.020813
BibTeX
@article{Miller2014,
author = {Miller, Brian J. and Culpepper, Nick and Rapaport, Mark H.},
title = {C-Reactive Protein Levels in Schizophrenia},
journal = {Clinical Schizophrenia & Related Psychoses},
year = {2014},
volume = {7},
number = {4},
pages = {223--230},
doi = {10.3371/csrp.micu.020813}
}
EUVIMED